Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Octreotide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR2 known ✓ | P30874 | 19/20 | 0.45 |
| ▸ | SSTR5 known ✓ | P35346 | 12/20 | 0.45 |
| ▸ | SSTR4 known ✓ | P31391 | 10/20 | 0.45 |
| ▸ | SSTR3 known ✓ | P32745 | 8/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Octreotide SCHEMBL247589 | 0.88 | SSTR2 (0.57) | SSTR2SSTR5SSTR4SSTR3 | |
| Octreotide SCHEMBL15570084 | 0.79 | SSTR2 (0.65) | SSTR2SSTR5SSTR4SSTR3 | |
| Octreotide SCHEMBL725387 | 0.78 | SSTR2 (0.73) | SSTR2SSTR5SSTR4SSTR3 | |
| Octreotide SCHEMBL6066965 | 0.78 | SSTR2 (0.73) | SSTR2SSTR5SSTR4SSTR3 | |
| Octreotide SCHEMBL320745 | 0.77 | SSTR2 (0.76) | SSTR2SSTR5SSTR4SSTR3 | |
| Octreotide SCHEMBL2435867 | 0.71 | SSTR2 (0.71) | SSTR2SSTR5SSTR4SSTR3 | |
| Octreotide SCHEMBL19816086 | 0.71 | SSTR2 (0.74) | SSTR2SSTR5SSTR4SSTR3 | |
| Octreotide SCHEMBL2330976 | 0.71 | SSTR2 (0.54) | SSTR2SSTR5SSTR4SSTR3 | |
| Octreotide SCHEMBL16896858 | 0.69 | SSTR2 (0.72) | SSTR2SSTR5SSTR4SSTR3 | |
| Octreotide SCHEMBL2830104 | 0.68 | SSTR2 (0.95) | SSTR2SSTR5SSTR4SSTR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1545544-A2 | COMBINATIONS OF DRUGS FOR THE TREATMENT OF NEOPLASMS | Combinatorx, Incorporated (US) | 2005-06-29 | — | — | EP | disclosed |
| WO-2004007676-A2 | COMBINATION THERAPY FOR THE TREATMENT OF NEOPLASMS | COMBINATORX, INCORPORATED (US) | 2004-01-22 | — | — | WO | disclosed |
| WO-2004006842-A2 | COMBINATIONS OF DRUGS FOR THE TREATMENT OF NEOPLASMS | COMBINATORX, INCORPORATED (US) | 2004-01-22 | — | — | WO | disclosed |